BioAtla, Inc.
BCAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $56 | $567 | $183 | $11,650 |
| Gross Profit | -$56 | -$567 | -$183 | -$11,650 |
| % Margin | – | – | – | – |
| R&D Expenses | $9,539 | $13,684 | $12,355 | $11,650 |
| G&A Expenses | $0 | $4,963 | $5,259 | $4,594 |
| SG&A Expenses | $4,194 | $4,963 | $5,259 | $4,594 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$567 | -$183 | -$11,650 |
| Operating Expenses | $13,733 | $18,080 | $17,431 | $4,594 |
| Operating Income | -$13,789 | -$18,647 | -$17,614 | -$16,244 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1,989 | -$64 | $2,280 | $1,360 |
| Pre-Tax Income | -$15,778 | -$18,711 | -$15,334 | -$14,884 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$15,778 | -$18,711 | -$15,334 | -$14,884 |
| % Margin | – | – | – | – |
| EPS | -0.27 | -0.32 | -0.26 | -0.3 |
| % Growth | 15.6% | -23.1% | 13.3% | – |
| EPS Diluted | -0.27 | -0.32 | -0.26 | -0.3 |
| Weighted Avg Shares Out | 58,745 | 58,504 | 58,249 | 49,950 |
| Weighted Avg Shares Out Dil | 58,745 | 58,504 | 58,249 | 49,950 |
| Supplemental Information | – | – | – | – |
| Interest Income | $133 | $233 | $400 | $554 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $56 | $115 | $183 | $228 |
| EBITDA | -$15,722 | -$18,532 | -$17,431 | -$16,016 |
| % Margin | – | – | – | – |